Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,288 | -44,757 | -17,585 | -45,634 | -32,483 |
| Depreciation Amortization | 569 | 247 | 49 | 134 | 89 |
| Accounts payable and accrued liabilities | 2,804 | 6,522 | 331 | 398 | -133 |
| Other Working Capital | 11,228 | 4,701 | -6,668 | -5,943 | -550 |
| Other Operating Activity | 7,591 | -279 | 2,022 | 11,149 | 10,659 |
| Operating Cash Flow | $-51,096 | $-33,566 | $-21,851 | $-39,896 | $-22,418 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -135,218 | N/A | N/A | N/A | N/A |
| PPE Investments | -342 | -193 | -99 | -1,193 | -1,150 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -500 | -500 |
| Other Investing Activity | 0 | 0 | 0 | -500 | -500 |
| Investing Cash Flow | $-135,560 | $-193 | $-99 | $-1,693 | $-1,650 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 228,352 | 228,308 | 229,904 | 176 | 176 |
| Other Financing Activity | 0 | 0 | 0 | 175,426 | 176,225 |
| Financing Cash Flow | $228,352 | $228,308 | $229,904 | $175,602 | $176,401 |
| Beginning Cash Position | 158,874 | 158,874 | 158,874 | 24,861 | 24,861 |
| End Cash Position | 200,570 | 353,423 | 366,828 | 158,874 | 177,194 |
| Net Cash Flow | $41,696 | $194,549 | $207,954 | $134,013 | $152,333 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,096 | -33,566 | -21,851 | -39,896 | -22,418 |
| Capital Expenditure | -342 | -193 | -99 | -1,193 | -1,150 |
| Free Cash Flow | -51,438 | -33,759 | -21,950 | -41,089 | -23,568 |